Literature DB >> 25947883

Clinical Benefit of American College of Chest Physicians Versus European Society of Cardiology Guidelines for Stroke Prophylaxis in Atrial Fibrillation.

Ambar A Andrade1,2, Brian F Gage3.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25947883      PMCID： PMC4579213          DOI： 10.1007/s11606-015-3378-3

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  6 in total

1.  Risk of bleeding with dabigatran in atrial fibrillation.

Authors:  Inmaculada Hernandez; Seo Hyon Baik; Antonio Piñera; Yuting Zhang
Journal:  JAMA Intern Med       Date:  2015-01       Impact factor: 21.873

2.  Cost-effectiveness of dabigatran for stroke prophylaxis in atrial fibrillation.

Authors:  Shimoli V Shah; Brian F Gage
Journal:  Circulation       Date:  2011-05-23       Impact factor: 29.690

3.  Preference-based antithrombotic therapy in atrial fibrillation: implications for clinical decision making.

Authors:  Malcolm Man-Son-Hing; Brian F Gage; Alan A Montgomery; Alistair Howitt; Richard Thomson; P J Devereaux; Joanne Protheroe; Tom Fahey; David Armstrong; Andreas Laupacis
Journal:  Med Decis Making       Date:  2005 Sep-Oct       Impact factor: 2.583

4.  Benefit of anticoagulation unlikely in patients with atrial fibrillation and a CHA2DS2-VASc score of 1.

Authors:  Leif Friberg; Mika Skeppholm; Andreas Terént
Journal:  J Am Coll Cardiol       Date:  2015-01-27       Impact factor: 24.094

5.  Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.

Authors:  Robert G Hart; Lesly A Pearce; Maria I Aguilar
Journal:  Ann Intern Med       Date:  2007-06-19       Impact factor: 25.391

6.  Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation.

Authors:  Elaine M Hylek; Carmella Evans-Molina; Carol Shea; Lori E Henault; Susan Regan
Journal:  Circulation       Date:  2007-05-21       Impact factor: 29.690
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.